Total Funding
91
73
Total FundingSeries A raised
Growth Score 91 in past quarter
-2 pts
Heat Score 73 in past quarter
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
54812
Cosomil is a pharmaceutical company that offers research and develops methods for diagnosing early-stage diseases, including cancer.
- Yu Kagami: CO- founder and CEOPast Role: Johnson & Johnson Innovative Medicine, Regulatory Affairs
- Shingo Sakamoto: CO- founder and Chief Technology Officer
About the Company
Cosomil develops early diagnostic drugs for diseases and provides research and development support to healthcare companies.